Do you want to know more about ILC2 involvement in chronic myeloid leukaemia?🤩 Read our new publication on #haematologica by Benedetta Fiordi et al. haematologica.org/article/view/h…

Great opportunity for a talented postdoc to work between our labs!

Recruiting! Join as a postdoc or PhD student at Imperial College London, working on the immunology of gestational cancers. How does a cancer allograft escape immune destruction? MHC I is suppressed but we see a 75% cure rate with anti-PD1 therapy. Why? Lessons to be learned.

Last week for students to apply for the In2scienceUK in2research programme! 2nd/3rd/4th year undergraduates from low socioeconomic backgrounds who are considering research careers can access mentoring and an 8 week research placement (next summer). in2scienceuk.org/in2research/in…

Save your place today at Solid Tumour Cellular Therapy Preceptorship on 11 October! It will cover all aspects of solid tumour cell therapy including procurement of starting materials, cell transfer adjuvant therapy, toxicity management, and more royalmarsden.nhs.uk/CellularTherapy

Our CSO, Sergio Quezada, will be in Boston to present at the Annual TIL Therapies Summit, taking place from October 2-4. His presentation, “Precision Cell Therapies Targeting Immunogenic Clonal Neoantigens in Lung Cancer," will take place at 8:30 ET on October 3. #TILSummit

Rafi Ahmed's 75th birthday symposium, addressing a room full of former trainees and their trainees "The best gift is seeing your wonderful science...It's incredible how lucky I've been. This is my message to you: whatever you do, being a good human being is the most important"

The lecture recordings for 'Ideas in contemporary Immunology: a symposium in memory of Av Mitchison ' can now be viewed here my.guestpix.com/Guest/Access/2…

We're looking for clinicians who are passionate about research to join our 3-year fully funded clinical PhD programme 🔬🩺 Projects are available with UCL, King's College London and Imperial College London 🗓️ Apply by 15 November 2023 crick.ac.uk/careers-study/…

Fantastic PhD programme positions open at the Francis Crick Institute, including one in my lab.

On Sunday Benedetta Fiordi will be present at the ESH (Haematology) Conference in Estoril (Portugal) with a poster on her interesting project on ACUTE MYELOID LEUKEMIA! Go to find out more about her results🤩

Thanks to DMM Journal with #DMMgrants and #SSAI for their travel grants in supporting my participation to #SITC2023 in San Diego.

The risk of blood clots largely disappears within 2 to 4 weeks after stopping hormone-based birth control, according to a new study in @BloodJournal. Read more: loom.ly/uqC2RnA Marc Blondon

Out today in Nature Cancer we had a great time collaborating with Michele De Palma and Mathias Heikenwaelder’s groups. We contributed in combining engineered dendritic cell progenitors with CAR-T cells in an aggressive glioma mouse model showing promising synergistic effects.

Happy for CONIPHER available to all! ⚠️Remember ALL related TRACERx 421 processed data are publicly avail: 👉doi.org/10.5281/zenodo… Explore them following the oustanding wiki in Python or R by Lucrezia Patruno and Maria in my and Nicholas McGranahan group 👉github.com/McGranahanLab/…

Our PI, Sergio Quezada has written a Nature Cancer commentary on neoantigen prediction along with our amazing EU funded collaborators: Achilles Therapeutics plc, Weizmann Institute of Science, DTU Health Tech and UCL Cancer Institute. Check it out here: rdcu.be/dtIHQ

Online Now: Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors dlvr.it/T8b8JK

📢 Currently recruiting healthy male participants for our cutting-edge study on #CognitiveImmunity Interested? Scan the QR code to join us!

Nature research paper: Clonal driver neoantigen loss under EGFR TKI and immune selection pressures go.nature.com/4hJsDxd

Cancer-associated Cachexia is a lethal metabolic syndrome marked by systemic inflammation, CNS appetite dysregulation, & muscle/fat loss—better characterized with imaging. Prevalent in cancers like pancreatic/lung, it's linked to IL-6, GDF-15, & tumor-driven energy drain. Trials